Your browser doesn't support javascript.
loading
Improving Outcomes in NSCLC: Optimum Dose Fractionation in Radical Radiotherapy Matters.
Brada, Michael; Forbes, Helen; Ashley, Susan; Fenwick, John.
Afiliación
  • Brada M; Department of Radiation Oncology, The Clatterbridge Cancer Centre NHS Foundation Trust, Wirral, United Kingdom; Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, University of Liverpool, Liverpool, United Kingdom. Electronic address: michael.brada@liverpool.a
  • Forbes H; Department of Radiation Oncology, The Clatterbridge Cancer Centre NHS Foundation Trust, Wirral, United Kingdom; National Clinical Analysis and Specialised Applications Team (NATCANSAT), The Clatterbridge Cancer Centre NHS Foundation Trust, Wirral, United Kingdom.
  • Ashley S; Department of Radiation Oncology, The Clatterbridge Cancer Centre NHS Foundation Trust, Wirral, United Kingdom.
  • Fenwick J; Department of Radiation Oncology, The Clatterbridge Cancer Centre NHS Foundation Trust, Wirral, United Kingdom; Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, University of Liverpool, Liverpool, United Kingdom.
J Thorac Oncol ; 17(4): 532-543, 2022 04.
Article en En | MEDLINE | ID: mdl-35092841
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans / Infant Idioma: En Revista: J Thorac Oncol Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans / Infant Idioma: En Revista: J Thorac Oncol Año: 2022 Tipo del documento: Article